Compare MSN & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSN | ADIL |
|---|---|---|
| Founded | 1948 | 2010 |
| Country | United States | United States |
| Employees | N/A | 6 |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2M | 11.4M |
| IPO Year | 1995 | 2017 |
| Metric | MSN | ADIL |
|---|---|---|
| Price | $0.38 | $3.95 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.33 |
| AVG Volume (30 Days) | ★ 179.5K | 35.0K |
| Earning Date | 11-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.09 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $77,829,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.34 | $0.13 |
| 52 Week High | $0.77 | $7.20 |
| Indicator | MSN | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 34.03 | 41.70 |
| Support Level | $0.35 | $3.80 |
| Resistance Level | $0.41 | $4.94 |
| Average True Range (ATR) | 0.03 | 0.40 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 6.39 | 31.46 |
Emerson Radio Corp designs, sources, imports, markets, sells and licenses to certain licensees a variety of houseware and consumer electronic products, both domestically and internationally, under the Emerson brand name. The Company's core business consists of selling, distributing, and licensing various low and moderately priced houseware and consumer electronic products in various categories. Its products are Houseware Products consist Microwave Ovens, Compact Refrigerators, Toaster Ovens, Heaters and Fans; Audio Products consist Clock Radios, Bluetooth Speakers, Karaoke Machines, Wireless Charging; and Other consist Televisions, Security Products, Massagers. It operates in One segment. Majority of revenue comes from United States.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.